Elionco, Inc researches and develops products to aid in diagnosis and treatments of major human diseases including cancer, neurological diseases and other metabolic diseases. Elionco also provides drug development consulting services.
Elionco approaches the innovative technologies by partnering with academic and industries. Elionco is the bridge between innovation and applications. Our potential products include immunological and small molecule based drug leads as well as cell-based assay platforms for drug screening.